Jiang Hua Mei
Director/Board Member presso SHANGHAI UNIVERSAL BIOTECH CO.,LTD.
Profilo
Jiang Hua Mei is currently working as a Partner & Investment Director at Shanghai Changjiang Guohong Investment Management Co. Ltd.
Additionally, Mr. Mei holds the position of Director-Investment Division at Shanghai Grandyangtze Capital Co. Ltd.
since 2016.
Furthermore, Mr. Mei is a Member-Supervisory Board at Shanghai Universal Biotech Co., Ltd.
starting from 2018.
In the past, Mr. Mei worked as a Director at PharmaBlock Sciences (Nanjing), Inc. from 2014 to 2018.
Mr. Mei also served as a Member-Supervisory Board at TransThera Sciences (Nanjing), Inc. Regarding education, Mr. Mei obtained an MBA from Shanghai Jiao Tong University in 2015.
Mr. Mei completed their undergraduate degree at Zhejiang University in 2000 and their graduate degree from the same university in 2003.
Posizioni attive di Jiang Hua Mei
| Società | Posizione | Inizio |
|---|---|---|
| SHANGHAI UNIVERSAL BIOTECH CO.,LTD. | Director/Board Member | 01/11/2018 |
Shanghai Changjiang Guohong Investment Management Co. Ltd.
 Shanghai Changjiang Guohong Investment Management Co. Ltd. Investment ManagersFinance Shanghai Changjiang Guohong Investment Management Co. Ltd. is a private equity firm headquartered in Shanghai, China. The firm was established in 2007. | Director/Board Member | - |
| Shanghai Grandyangtze Capital Co. Ltd. | Corporate Officer/Principal | 01/06/2016 |
Precedenti posizioni note di Jiang Hua Mei
| Società | Posizione | Fine |
|---|---|---|
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Director/Board Member | 09/11/2022 |
| PHARMABLOCK SCIENCES (NANJING), INC. | Director/Board Member | 01/11/2018 |
TransThera Sciences (Nanjing), Inc.
 TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China. | Director/Board Member | - |
Formazione di Jiang Hua Mei
| Shanghai Jiao Tong University | Masters Business Admin |
| Zhejiang University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PHARMABLOCK SCIENCES (NANJING), INC. | Commercial Services |
| SHANGHAI UNIVERSAL BIOTECH CO.,LTD. | Distribution Services |
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Health Technology |
| Aziende private | 3 |
|---|---|
TransThera Sciences (Nanjing), Inc.
TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China. | Health Technology |
| Shanghai Grandyangtze Capital Co. Ltd. | |
Shanghai Changjiang Guohong Investment Management Co. Ltd.
Shanghai Changjiang Guohong Investment Management Co. Ltd. Investment ManagersFinance Shanghai Changjiang Guohong Investment Management Co. Ltd. is a private equity firm headquartered in Shanghai, China. The firm was established in 2007. | Finance |
- Borsa valori
- Insiders
- Jiang Hua Mei
